MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$13.59+0.05 (+0.37%)
Close on Nov 20, 2026Market cap $174.43MP/E –Yield –
MediWound gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $3.25M, up 23.5% from the year before. The highest annual figure on record is $19.94M in fiscal 2019.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.25M | +23.5% |
| FY2024 | Dec 31, 2024 | $2.63M | -26.4% |
| FY2023 | Dec 31, 2023 | $3.58M | -72.8% |
| FY2022 | Dec 31, 2022 | $13.17M | +50.1% |
| FY2021 | Dec 31, 2021 | $8.77M | +16.2% |
| FY2020 | Dec 31, 2020 | $7.55M | -62.2% |
| FY2019 | Dec 31, 2019 | $19.94M | +1418.7% |
| FY2018 | Dec 31, 2018 | $1.31M | +43.0% |
| FY2017 | Dec 31, 2017 | $918.00K | – |
| FY2016 | Dec 31, 2016 | -$600.00K | – |
| FY2015 | Dec 31, 2015 | -$1.92M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $337.00K | -69.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.34M | -43.2% |
| Q2 FY2024 | Jun 30, 2024 | $447.00K | -63.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.14M | -93.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.11M | +176.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.36M | +1063.1% |
| Q2 FY2020 | Jun 30, 2020 | $1.22M | – |
| Q2 FY2019 | Jun 30, 2019 | $17.27M | – |
| Q2 FY2018 | Jun 30, 2018 | $402.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $203.00K | – |
See a number that looks wrong?